Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

Similar articles for PubMed (Select 24658073)

1.

Recipient-related clinical risk factors for primary graft dysfunction after lung transplantation: a systematic review and meta-analysis.

Liu Y, Liu Y, Su L, Jiang SJ.

PLoS One. 2014 Mar 21;9(3):e92773. doi: 10.1371/journal.pone.0092773. eCollection 2014. Review.

2.

Clinical risk factors for primary graft dysfunction after lung transplantation.

Diamond JM, Lee JC, Kawut SM, Shah RJ, Localio AR, Bellamy SL, Lederer DJ, Cantu E, Kohl BA, Lama VN, Bhorade SM, Crespo M, Demissie E, Sonett J, Wille K, Orens J, Shah AS, Weinacker A, Arcasoy S, Shah PD, Wilkes DS, Ware LB, Palmer SM, Christie JD; Lung Transplant Outcomes Group.

Am J Respir Crit Care Med. 2013 Mar 1;187(5):527-34. doi: 10.1164/rccm.201210-1865OC. Epub 2013 Jan 10.

3.

Elevated pulmonary artery pressure is a risk factor for primary graft dysfunction following lung transplantation for idiopathic pulmonary fibrosis.

Fang A, Studer S, Kawut SM, Ahya VN, Lee J, Wille K, Lama V, Ware L, Orens J, Weinacker A, Palmer SM, Crespo M, Lederer DJ, Deutschman CS, Kohl BA, Bellamy S, Demissie E, Christie JD; Lung Transplant Outcomes Group.

Chest. 2011 Apr;139(4):782-7. doi: 10.1378/chest.09-2806. Epub 2010 Sep 23.

4.

Risk factors and survival impact of primary graft dysfunction after lung transplantation in a single institution.

Samano MN, Fernandes LM, Baranauskas JC, Correia AT, Afonso JE Jr, Teixeira RH, Caramori ML, Pêgo-Fernandes PM, Jatene FB.

Transplant Proc. 2012 Oct;44(8):2462-8. doi: 10.1016/j.transproceed.2012.07.134.

PMID:
23026621
5.

Risk factors for early primary graft dysfunction after lung transplantation: a registry study.

Kuntz CL, Hadjiliadis D, Ahya VN, Kotloff RM, Pochettino A, Lewis J, Christie JD.

Clin Transplant. 2009 Nov-Dec;23(6):819-30. doi: 10.1111/j.1399-0012.2008.00951.x. Epub 2009 Feb 20.

PMID:
19239481
6.

Variation in PTX3 is associated with primary graft dysfunction after lung transplantation.

Diamond JM, Meyer NJ, Feng R, Rushefski M, Lederer DJ, Kawut SM, Lee JC, Cantu E, Shah RJ, Lama VN, Bhorade S, Crespo M, Demissie E, Sonett J, Wille K, Orens J, Weinacker A, Weill D, Arcasoy S, Shah PD, Belperio JA, Wilkes D, Ware LB, Palmer SM, Christie JD; Lung Transplant Outcomes Group.

Am J Respir Crit Care Med. 2012 Sep 15;186(6):546-52. Epub 2012 Jul 19.

7.

Factors associated with early graft dysfunction in cystic fibrosis patients receiving primary bilateral lung transplantation.

Felten ML, Sinaceur M, Treilhaud M, Roze H, Mornex JF, Pottecher J, Journois D, Fischler M.

Eur J Cardiothorac Surg. 2012 Mar;41(3):686-90. doi: 10.1093/ejcts/ezr019.

PMID:
22345188
8.

Preoperative plasma club (clara) cell secretory protein levels are associated with primary graft dysfunction after lung transplantation.

Shah RJ, Wickersham N, Lederer DJ, Palmer SM, Cantu E, Diamond JM, Kawut SM, Lama VN, Bhorade S, Crespo M, Demissie E, Sonett J, Wille K, Orens J, Weinacker A, Shah P, Arcasoy S, Wilkes DS, Christie JD, Ware LB; Lung Transplant Outcomes Group.

Am J Transplant. 2014 Feb;14(2):446-52. doi: 10.1111/ajt.12541. Epub 2014 Jan 8.

9.

Elevated plasma long pentraxin-3 levels and primary graft dysfunction after lung transplantation for idiopathic pulmonary fibrosis.

Diamond JM, Lederer DJ, Kawut SM, Lee J, Ahya VN, Bellamy S, Palmer SM, Lama VN, Bhorade S, Crespo M, Demissie E, Sonett J, Wille K, Orens J, Shah PD, Weinacker A, Weill D, Kohl BA, Deutschman CC, Arcasoy S, Shah AS, Belperio JA, Wilkes D, Reynolds JM, Ware LB, Christie JD; Lung Transplant Outcomes Group.

Am J Transplant. 2011 Nov;11(11):2517-22. doi: 10.1111/j.1600-6143.2011.03702.x. Epub 2011 Aug 22.

10.

Soluble p-selectin and the risk of primary graft dysfunction after lung transplantation.

Kawut SM, Okun J, Shimbo D, Lederer DJ, De Andrade J, Lama V, Shah A, Milstone A, Ware LB, Weinacker A, Demissie E, Christie JD; Lung Transplant Outcomes Group.

Chest. 2009 Jul;136(1):237-44. doi: 10.1378/chest.08-2697. Epub 2009 Mar 2.

11.

Twinned single-lung transplantation: a privileged model for the study of recipient-dependent factors of outcome.

Olland A, Santelmo N, Orsini B, Falcoz PE, Dorent R, Mal H, Thomas P, Massard G.

Eur J Cardiothorac Surg. 2012 Jun;41(6):1357-64; discussion 1364-5. doi: 10.1093/ejcts/ezr234. Epub 2012 Jan 12.

PMID:
22241010
12.

Validation of the proposed International Society for Heart and Lung Transplantation grading system for primary graft dysfunction after lung transplantation.

Prekker ME, Nath DS, Walker AR, Johnson AC, Hertz MI, Herrington CS, Radosevich DM, Dahlberg PS.

J Heart Lung Transplant. 2006 Apr;25(4):371-8. Epub 2006 Feb 28.

PMID:
16563963
13.

Elevated plasma angiopoietin-2 levels and primary graft dysfunction after lung transplantation.

Diamond JM, Porteous MK, Cantu E, Meyer NJ, Shah RJ, Lederer DJ, Kawut SM, Lee J, Bellamy SL, Palmer SM, Lama VN, Bhorade SM, Crespo M, Demissie E, Wille K, Orens J, Shah PD, Weinacker A, Weill D, Arcasoy S, Wilkes DS, Ware LB, Christie JD; Lung Transplant Outcomes Group.

PLoS One. 2012;7(12):e51932. doi: 10.1371/journal.pone.0051932. Epub 2012 Dec 19.

14.

Latent class analysis identifies distinct phenotypes of primary graft dysfunction after lung transplantation.

Shah RJ, Diamond JM, Cantu E, Lee JC, Lederer DJ, Lama VN, Orens J, Weinacker A, Wilkes DS, Bhorade S, Wille KM, Ware LB, Palmer SM, Crespo M, Localio AR, Demissie E, Kawut SM, Bellamy SL, Christie JD.

Chest. 2013 Aug;144(2):616-22. doi: 10.1378/chest.12-1480.

15.

Obesity and primary graft dysfunction after lung transplantation: the Lung Transplant Outcomes Group Obesity Study.

Lederer DJ, Kawut SM, Wickersham N, Winterbottom C, Bhorade S, Palmer SM, Lee J, Diamond JM, Wille KM, Weinacker A, Lama VN, Crespo M, Orens JB, Sonett JR, Arcasoy SM, Ware LB, Christie JD; Lung Transplant Outcomes Group.

Am J Respir Crit Care Med. 2011 Nov 1;184(9):1055-61. doi: 10.1164/rccm.201104-0728OC.

16.

Primary graft dysfunction and long-term pulmonary function after lung transplantation.

Whitson BA, Prekker ME, Herrington CS, Whelan TP, Radosevich DM, Hertz MI, Dahlberg PS.

J Heart Lung Transplant. 2007 Oct;26(10):1004-11.

PMID:
17919620
17.

Effect of single vs bilateral lung transplantation on plasma surfactant protein D levels in idiopathic pulmonary fibrosis.

Sims MW, Beers MF, Ahya VN, Kawut SM, Sims KD, Lederer DJ, Palmer SM, Wille K, Lama VN, Shah PD, Orens JB, Bhorade S, Crespo M, Weinacker A, Demissie E, Bellamy S, Christie JD, Ware LB; Lung Transplant Outcomes Group.

Chest. 2011 Aug;140(2):489-96. doi: 10.1378/chest.10-2065. Epub 2011 Feb 24.

18.

Primary graft dysfunction.

Lee JC, Christie JD.

Clin Chest Med. 2011 Jun;32(2):279-93. doi: 10.1016/j.ccm.2011.02.007. Review.

PMID:
21511090
19.

Concomitant endothelin-1 overexpression in lung transplant donors and recipients predicts primary graft dysfunction.

Salama M, Andrukhova O, Hoda MA, Taghavi S, Jaksch P, Heinze G, Klepetko W, Aharinejad S.

Am J Transplant. 2010 Mar;10(3):628-36. doi: 10.1111/j.1600-6143.2009.02957.x. Epub 2010 Jan 5.

20.

Primary graft dysfunction after liver transplantation.

Chen XB, Xu MQ.

Hepatobiliary Pancreat Dis Int. 2014 Apr;13(2):125-37. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk